SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aclara Biosciences (ACLA) - The next small thing?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (10)1/30/2002 11:34:58 PM
From: tuck   of 16
 
Nigel and thread,

Some Aclara commentary, FWIW. See the last three large paragraphs of this post:

Message 16987383

I might add that part of Aclara's future selling points is that their chips can be easily integrated with "existing" equipment. This is true in terms of plate handling equipment, since the chips are plate sized. The liquid dispensing bottleneck mentioned in the above post needs to go away before that is really true. At that point, Aclara's chips could gain traction very quickly. They are cheaper than Caliper's, and maybe better, and won't require an Agilent work station.

Not sure what to make of their protein chemistries or their upcoming Plurex product. At the lab automation show, I was told that so many prospective partners were interested in that product that the hard part would be choosing the right one. Let's hope so, and let's hope they're discriminating. One of their current partners is -- gulp -- Roche.

Need to do more research; I'm interested because it looks so cheap. But given the fundamental situation, I think I've got some time, and other things -- as noted in that post -- are more urgent now.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext